Viewing Study NCT01225406


Ignite Creation Date: 2025-12-26 @ 5:18 PM
Ignite Modification Date: 2026-01-01 @ 4:42 AM
Study NCT ID: NCT01225406
Status: COMPLETED
Last Update Posted: 2020-07-17
First Post: 2010-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None This Study is Designed to Collect Treatment Data of Thai … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Third line ARV therapy View
None HIV RNA View
None Absolute CD4+ T cell count View
None serious adverse events (SAEs) View
None Drug resistance View